Browse by Audience
Skip to content
Papers of the Week
Safety and persistence of dimethyl fumarate as a treatment for relapsing-remitting multiple-sclerosis.
Abstract
Dimethyl fumarate is a medication approved for the treatment of relapsing-remitting multiple sclerosis. The purpose of the study was to evaluate the safety and persistence of dimethyl fumarate in clinical practice and analyze the occurrence of lymphopenia is patients treated with dimethyl fumarate over a period of at least 6 months.